SCM
KPTI icon

Sterling Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History

Sterling Capital Management’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44K Buy
+352
New +$3.05K ﹤0.01% 2798

Other funds holding KPTI

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
MLA
MB, Levis & Associates Center Valley, Pennsylvania $271M AUM 15.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
WBC
West Branch Capital Amherst, Massachusetts $430M AUM 41.9% 1-Year Est. Return

Sterling Capital Management's KPTI Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Karyopharm Therapeutics (KPTI) in Q2 2026: 352 shares worth $3.44K. The stake represents ﹤0.01% of the portfolio and ranks #2798 among its holdings.

9 funds tracked by Wall St. Rank hold KPTI as of Q2 2026.

  • Sterling Capital Management held 352 shares of Karyopharm Therapeutics worth $3.44K as of Q2 2026.
  • Karyopharm Therapeutics was a new Sterling Capital Management position in Q2 2026.
  • Karyopharm Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2798 holding.
  • 9 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.